University of Birmingham: New Spin-out IMS Solutions to Commercialise Groundbreaking 'steroid Fingerprint' Technology
September 22, 2026
September 22, 2026
BIRMINGHAM, England, Sept. 22 -- The University of Birmingham posted the following news:
* * *
New spin-out IMS Solutions to commercialise groundbreaking 'steroid fingerprint' technology
IMS is developing a world-first stratification test for Polyendocrine Metabolic Ovarian Syndrome and a more accurate diagnostic for Adrenocortical Carcinoma
22 September 2026
The University of Birmingham and Imperial College London have a . . .
* * *
New spin-out IMS Solutions to commercialise groundbreaking 'steroid fingerprint' technology
IMS is developing a world-first stratification test for Polyendocrine Metabolic Ovarian Syndrome and a more accurate diagnostic for Adrenocortical Carcinoma
22 September 2026
The University of Birmingham and Imperial College London have a . . .
